Bamlanivimab is the first coronavirus antibody treatment to be approved in Canada.

The antiviral drug, which was recently used to treat U.S. President Donald Trump, also appeared to reduce the risk of death in some patients.

The Department of Health and Human Services said Trump has secured 500,000 treatments of the drug through September, representing 100 per cent of Gilead’s July production capacity and 90 per cent of its capacity in August and September.

A new study has found that dexamethasone might help reduce deaths among COVID-19 patients who develop serious breathing problems.

Nearly 70 per cent of patients tested in the U.S., Europe, Canada and Japan improved after taking the Gilead Sciences drug remdesivir, but eight of the patients worsened while seven died.

The trial drug is described as having two functions, with one being "physically blocking the door to the virus so it cannot enter" a person's body.

Hydroxychloroquine is being trialed as a therapy for COVID-19 at North Vancouver's Lynn Valley Care Centre.

B.C. has introduced new clinical guidance that could make it easier for people struggling with addictions to get access to safe drugs.

A new, 1,500-bed hospital specially built for virus patients opened days after a 1,000-bed hospital with prefabricated wards and isolation rooms began taking patients.